#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polymyositis Arterial disorder B-cell small lymphocytic lymphoma recurrent Activated PI3 kinase delta syndrome Primary biliary cholangitis Ewing's sarcoma metastatic Prophylaxis against transplant rejection Infantile spasms Pulmonary tuberculosis Amyotrophic lateral sclerosis gene carrier Nasopharyngeal cancer Plasma cell myeloma refractory Fibrodysplasia ossificans progressiva Liposarcoma metastatic Infective uveitis More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Life with Disease Adrenogenital syndrome – Treatment Medulloblastoma – Trials in Disease Haemophilia B with anti factor IX – Diagnostics SAPHO syndrome Pleomorphic leiomyosarcoma – Life with Disease Hereditary motor and sensory neuropathy – Trials in Disease Anaplastic thyroid cancer – Basic Information Ornithine transcarbamoylase deficiency – Trials in Disease Chondrosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aup1602-C Verapamil Hydrochloride Tiaprofenic Acid Pegcetacoplan ABY-271 ATIGOTATUG SAR445399 Lysine Hydrochloride Ursodeoxycholic Acid Belzutifan Cedazuridine Enoxaparin Sodium PRT3789 [18F]Fapi-74 Df1001 Msv/As Terbinafine Hydrochloride Aripiprazole Parsaclisib Hydrochloride Vepdegestrant More therapies…

    Learn about Your Condition

    Brain cancer metastatic Procedural haemorrhage Pruritus Neonatal hyperglycaemia Mantle cell lymphoma Procedural headache Arthritis infective Rectal cancer recurrent Injury Compulsive sexual behaviour Eye inflammation Oedema peripheral Adenocarcinoma pancreas Craniopharyngioma Substance use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Primary biliary cholangitis

  • Study on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid

    Not recruiting

    4 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Elafibranor
    Belgium France Germany Italy Spain

  • Study of Elafibranor in Adults with Primary Biliary Cholangitis Who Don’t Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment

    Not recruiting

    3 1
    Investigated Drugs:
    • Elafibranor
    Czechia France Germany Italy Poland Romania +1

  • Study on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Belgium Croatia Czechia Estonia France Germany +6

  • Study on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Volixibat
    Belgium France Germany Italy The Netherlands Spain

  • Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Linerixibat
    Belgium Bulgaria Czechia France Germany Greece +3

  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Not recruiting

    1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Golexanolone
    Germany Greece Hungary Italy Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!